COOCooper Companies (The)
Is it growing?
Neither accelerating nor breaking down: earnings up +43% year on year, but operating margin narrowing (−5.4 points).
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +8% a year.
Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.
Trailing-twelve-month operating margin, 13.0% now against 18.3% a year earlier.
All from SEC EDGAR, as of Jul 31, 2026.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is COO growing?
Cooper Companies (The) has grown revenue 6.4% a year over three years and 8.3% a year over five, with earnings per share compounding at 28%.
Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +8.3%
Revenue growth, 5-year rate · +6.4% over three · growth has slowed since the five-year average
- Earnings per share, 3-year rate
- +28%
Earnings per share, 3-year rate · revenue +6.4% · earnings outgrew revenue: margins or the share count worked for shareholders
- Years of annual history on file
- 18
Years of annual history on file · FY2008 to FY2025, as filed
Details›
- Revenue FY2021
- $2.92B
- Revenue FY2022
- $3.31B
- Revenue FY2023
- $3.59B
- Revenue FY2024
- $3.90B
- Revenue FY2025
- $4.09B
Annual income statements as filed with the SEC.
Medical Instruments & Supplies
The closest names by size in the same industry